Literature DB >> 25169573

Genetics of diabetes complications.

Sami Alkayyali1, Valeriya Lyssenko.   

Abstract

Chronic hyperglycemia and duration of diabetes are the major risk factors associated with development of micro- and macrovascular complications of diabetes. Although it is believed that hyperglycemia induces damage to the particular cell subtypes, e.g., mesangial cells in the renal glomerulus, capillary endothelial cells in the retina, and neurons and Schwann cells in peripheral nerves, the exact mechanisms underlying these damaging defects are not yet well understood. Clustering of micro- and macrovascular complications in families of patients with diabetes suggests a strong genetic susceptibility. However, until now only a handful number of genetic variants were reported to be associated with either nephropathy (ACE, ELMO1, FRMD3, and AKR1B1) or retinopathy (VEGF, AKR1B1, and EPO), and only a few studies were carried out for genetic susceptibility to cardiovascular diseases (ADIPOQ, GLUL) in patients with diabetes. It is, therefore, obvious that the accumulation of more data from larger studies and better phenotypically characterized cohorts is needed to facilitate genetic discoveries and unravel novel insights into the pathogenesis of diabetic complications.

Entities:  

Mesh:

Year:  2014        PMID: 25169573     DOI: 10.1007/s00335-014-9543-x

Source DB:  PubMed          Journal:  Mamm Genome        ISSN: 0938-8990            Impact factor:   2.957


  156 in total

1.  [Diabetes mellitus and its degenerative complications: a prospective study of 4,400 patients observed between 1947 and 1973 (author's transl)].

Authors:  J Pirart
Journal:  Diabete Metab       Date:  1977-06

2.  Association analysis of -429T/C and -374T/A polymorphisms of receptor of advanced glycation end products (RAGE) gene in Malaysian with type 2 diabetic retinopathy.

Authors:  Zhi Xiang Ng; Umah Rani Kuppusamy; Iqbal Tajunisah; Kenneth Choong Sian Fong; Kek Heng Chua
Journal:  Diabetes Res Clin Pract       Date:  2011-12-09       Impact factor: 5.602

3.  Familial factors determine the development of diabetic nephropathy in patients with IDDM.

Authors:  M Quinn; M C Angelico; J H Warram; A S Krolewski
Journal:  Diabetologia       Date:  1996-08       Impact factor: 10.122

4.  Mortality attributable to diabetes: estimates for the year 2010.

Authors:  Gojka Roglic; Nigel Unwin
Journal:  Diabetes Res Clin Pract       Date:  2009-11-14       Impact factor: 5.602

5.  Reactive oxygen species mediate a cellular 'memory' of high glucose stress signalling.

Authors:  M A Ihnat; J E Thorpe; C D Kamat; C Szabó; D E Green; L A Warnke; Z Lacza; A Cselenyák; K Ross; S Shakir; L Piconi; R C Kaltreider; A Ceriello
Journal:  Diabetologia       Date:  2007-05-17       Impact factor: 10.122

6.  An (A-C)n dinucleotide repeat polymorphic marker at the 5' end of the aldose reductase gene is associated with early-onset diabetic retinopathy in NIDDM patients.

Authors:  B C Ko; K S Lam; N M Wat; S S Chung
Journal:  Diabetes       Date:  1995-07       Impact factor: 9.461

7.  Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.

Authors:  L P Aiello; R L Avery; P G Arrigg; B A Keyt; H D Jampel; S T Shah; L R Pasquale; H Thieme; M A Iwamoto; J E Park
Journal:  N Engl J Med       Date:  1994-12-01       Impact factor: 91.245

8.  A genome-wide scan for coronary heart disease suggests in Indo-Mauritians a susceptibility locus on chromosome 16p13 and replicates linkage with the metabolic syndrome on 3q27.

Authors:  S Francke; M Manraj; C Lacquemant; C Lecoeur; F Leprêtre; P Passa; A Hebe; L Corset; S L Yan; S Lahmidi; S Jankee; T K Gunness; U S Ramjuttun; V Balgobin; C Dina; P Froguel
Journal:  Hum Mol Genet       Date:  2001-11-15       Impact factor: 6.150

9.  Genetic examination of SETD7 and SUV39H1/H2 methyltransferases and the risk of diabetes complications in patients with type 1 diabetes.

Authors:  Anna Syreeni; Assam El-Osta; Carol Forsblom; Niina Sandholm; Maikki Parkkonen; Lise Tarnow; Hans-Henrik Parving; Amy J McKnight; Alexander P Maxwell; Mark E Cooper; Per-Henrik Groop
Journal:  Diabetes       Date:  2011-09-06       Impact factor: 9.461

10.  Knockdown of glyoxalase 1 mimics diabetic nephropathy in nondiabetic mice.

Authors:  Ferdinando Giacco; Xueliang Du; Vivette D D'Agati; Ross Milne; Guangzhi Sui; Michele Geoffrion; Michael Brownlee
Journal:  Diabetes       Date:  2013-09-23       Impact factor: 9.461

View more
  6 in total

Review 1.  Diabetes mellitus: The epidemic of the century.

Authors:  Akram T Kharroubi; Hisham M Darwish
Journal:  World J Diabetes       Date:  2015-06-25

2.  Novel Genetic Actors of Diabetes-Associated Microvascular Complications: Retinopathy, Kidney Disease and Neuropathy.

Authors:  Samaneh Davoudi; Lucia Sobrin
Journal:  Rev Diabet Stud       Date:  2016-01-25

Review 3.  Zebrafish as a Model for the Study of Microvascular Complications of Diabetes and Their Mechanisms.

Authors:  Karl Heckler; Jens Kroll
Journal:  Int J Mol Sci       Date:  2017-09-19       Impact factor: 5.923

4.  Embryo-Protective Effects of Cerium Oxide Nanoparticles against Gestational Diabetes in Mice.

Authors:  Zeinab Vafaei-Pour; Mohammad Shokrzadeh; Monireh Jahani; Fatemeh Shaki
Journal:  Iran J Pharm Res       Date:  2018       Impact factor: 1.696

5.  Status and Trends of the Association Between Diabetic Nephropathy and Diabetic Retinopathy From 2000 to 2021: Bibliometric and Visual Analysis.

Authors:  Wenwen Lin; Yayong Luo; Fang Liu; Hangtian Li; Qian Wang; Zheyi Dong; Xiangmei Chen
Journal:  Front Pharmacol       Date:  2022-06-20       Impact factor: 5.988

6.  The Adolescent Cardio-Renal Intervention Trial (AdDIT): retinal vascular geometry and renal function in adolescents with type 1 diabetes.

Authors:  Paul Z Benitez-Aguirre; Tien Y Wong; Maria E Craig; Elizabeth A Davis; Andrew Cotterill; Jennifer J Couper; Fergus J Cameron; Farid H Mahmud; Tim W Jones; Lauren A B Hodgson; R Neil Dalton; David B Dunger; Kim C Donaghue
Journal:  Diabetologia       Date:  2018-02-02       Impact factor: 10.122

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.